ON THE WEB
05/02/2018
EpicentRx Announces First Ever Treatment of Cancer Patient with Personalized, Custom-Made Viral Vaccines
05/02/2018
First Patient Treated With Next-Generation Immunotherapy at UC
02/19/2018
Will Immunotherapy Help Us Cure Lymphoma?
02/19/2018
Magnetic resonance imaging of RRx-001 pharmacodynamics in preclinical tumors
02/16/2018
The Currently Incurable Scientist: RRx-001 and the Impact of One CRC Patient-Chemist
01/08/2018
Leechburg woman leans on family as she battles neuroendocrine cancer
08/19/2015
EpicentRx Announces Publication of Phase 1 Trial Results for the Anti-Cancer Agent, RRx-001, in Lancet Oncology
11/17/2015
Reprogramming a Tumor for Death
